Protagenic Therapeutics, Inc.\new Logo

Protagenic Therapeutics, Inc.\new

Develops peptide-based therapeutics for stress-related neuropsychiatric disorders.

PTIX | US

Overview

Corporate Details

ISIN(s):
US74365N2027 (+1 more)
LEI:
Country:
United States of America
Address:
149 FIFTH AVENUE, 10010 NEW YORK

Description

Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on developing peptide-based therapeutics for stress-related disorders. The company's core technology is its TCAP (teneurin C-terminal associated peptide) platform, which utilizes neuropeptides to regulate the brain's stress response at a cellular level. This approach aims to counteract the 'Stress Feedback Loop' implicated in various neuropsychiatric and neurodegenerative conditions. Its lead drug candidate, PT00114, a synthetic TCAP, is being developed as a potential first-in-class treatment for disorders such as anxiety and depression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 22:52
DEF 14A
English 49.2 KB
2025-11-26 23:26
10-Q
English 1.2 MB
2025-11-26 22:18
8-K
English 116.8 KB
2025-11-14 23:04
NT 10-Q
English 10.8 KB
2025-11-05 22:21
8-K
English 77.3 KB
2025-10-31 22:08
8-K
English 25.2 MB
2025-10-24 23:29
424B5
English 116.4 KB
2025-10-24 19:40
PRIMARY DOCUMENT
English 7.4 KB
2025-09-17 18:21
8-K/A
English 118.2 KB
2025-09-10 22:06
10-QT
English 1.1 MB
2025-08-28 00:28
8-K/A
English 306.4 KB
2025-08-25 22:07 English 8.8 KB
2025-08-22 23:28
8-K
English 1.6 MB
2025-08-14 22:56
NT 10-Q
English 12.0 KB
2025-08-13 23:16
8-K
English 86.9 KB

Automate Your Workflow. Get a real-time feed of all Protagenic Therapeutics, Inc.\new filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Protagenic Therapeutics, Inc.\new

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Protagenic Therapeutics, Inc.\new via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.